These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10639472)

  • 1. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.
    Vuola JM; Puurula V; Anttila M; Mäkelä PH; Rautonen N
    Infect Immun; 2000 Feb; 68(2):960-4. PubMed ID: 10639472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.
    Geng Y; Berencsi K; Gyulai Z; Valyi-Nagy T; Gonczol E; Trinchieri G
    Infect Immun; 2000 Apr; 68(4):2245-53. PubMed ID: 10722626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
    Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME
    J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective DNA immunization against Chlamydia pneumoniae.
    Svanholm C; Bandholtz L; Castaños-Velez E; Wigzell H; Rottenberg ME
    Scand J Immunol; 2000 Apr; 51(4):345-53. PubMed ID: 10736106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.
    Rottenberg ME; Gigliotti Rothfuchs A; Gigliotti D; Ceausu M; Une C; Levitsky V; Wigzell H
    J Immunol; 2000 May; 164(9):4812-8. PubMed ID: 10779789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.
    Penttilä JM; Anttila M; Puolakkainen M; Laurila A; Varkila K; Sarvas M; Mäkelä PH; Rautonen N
    Infect Immun; 1998 Nov; 66(11):5113-8. PubMed ID: 9784511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.
    Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP
    J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.
    Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H
    J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.
    Yang X; HayGlass KT; Brunham RC
    J Immunol; 1996 Jun; 156(11):4338-44. PubMed ID: 8666805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.
    Williams DM; Grubbs BG; Pack E; Kelly K; Rank RG
    Infect Immun; 1997 Jul; 65(7):2876-82. PubMed ID: 9199462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
    Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
    Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma.
    Airenne S; Surcel HM; Bloigu A; Laitinen K; Saikku P; Laurila A
    APMIS; 2000 Feb; 108(2):139-44. PubMed ID: 10737459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection.
    Qiu H; Yang J; Bai H; Fan Y; Wang S; Han X; Chen L; Yang X
    Immunology; 2004 Apr; 111(4):453-61. PubMed ID: 15056383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
    Perry LL; Feilzer K; Caldwell HD
    J Immunol; 1997 Apr; 158(7):3344-52. PubMed ID: 9120292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections.
    Zhong GM; Peterson EM; Czarniecki CW; Schreiber RD; de la Maza LM
    Infect Immun; 1989 Jan; 57(1):152-7. PubMed ID: 2491833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung.
    Burián K; Hegyesi H; Buzás E; Endrész V; Kis Z; Falus A; Gönczöl E
    Immunol Lett; 2003 Oct; 89(2-3):229-36. PubMed ID: 14556983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
    Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM
    Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
    Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD
    J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.